Inhalation Sciences wins order for PreciseInhale system

Swedish inhalation research company Inhalation Sciences has received an order worth 1.6 million SEK (€147,694) for its PreciseInhale® system from an existing customer. The order includes the platform’s integrated inhaler actuator.

PreciseInhale includes a range of modules for controlled exposures to aerosols. The system is used by companies studying inhalation and aerosols in pre-clinical experiments.

The system’s ability to generate aerosols from existing and new inhalers is of particular interest to the inhaled drug development industry, according to a release from Inhalation Sciences.

PreciseInhale includes an integrated, automated module that is software-controlled and can connect to and generate aerosols from any inhaler.

"It’s a sure sign of just how strong our system is when a customer invests in another instrument,” said CEO Lena Heffler. “This sale is a clear indication that users realise the importance of the PreciseInhale technology we deliver, and that they are willing to expand their investment in it.”

Latest News

128 queries in 0.770 seconds.